We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$831M
AUM Growth
+$95.7M
Cap. Flow
-$18.2M
Cap. Flow %
-2.19%
Top 10 Hldgs %
37.16%
Holding
117
New
13
Increased
23
Reduced
36
Closed
11

Top Buys

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$28.2M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$16.5M
3
MRK icon
Merck
MRK
+$12.9M
4
AGN
Allergan plc
AGN
+$12.3M
5
ASMB icon
Assembly Biosciences
ASMB
+$11.8M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$26.1M
2
FOLD
Amicus Therapeutics
FOLD
+$20.1M
3
CELG
Celgene Corp
CELG
+$19M
4
IMMU
Immunomedics Inc
IMMU
+$18.6M
5
AERI
Aerie Pharmaceuticals
AERI
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 84.63%
2 Industrials 2.17%
3 Technology 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDP icon
51
Indaptus Therapeutics
INDP
$243M
$5.93M 0.71%
361
-133
-27% -$2.33M
NITE
52
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$5.93M 0.71%
233,711
– –
ADMS
53
DELISTED
Adamas Pharmaceuticals
ADMS
$5.75M 0.69%
808,924
-325,000
-29% -$2.92M
MGTX icon
54
MeiraGTx Holdings
MGTX
$1.08B
$5.53M 0.67%
320,896
-87,010
-21% -$1.23M
MDGL icon
55
Madrigal Pharmaceuticals
MDGL
$12.6B
$5.32M 0.64%
42,487
+14,000
+49% +$1.74M
EVLO
56
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$5.21M 0.63%
32,554
+12,195
+60% +$2.41M
SAGE
57
DELISTED
Sage Therapeutics
SAGE
$5.03M 0.6%
31,600
-5,500
-15% -$796K
INSP icon
58
Inspire Medical Systems
INSP
$1.47B
$4.88M 0.59%
+85,900
New +$4.64M
KYNB
59
Kyntra Bio
KYNB
$27.4M
$4.42M 0.53%
+3,250
New +$4.41M
WCG
60
DELISTED
Wellcare Health Plans, Inc.
WCG
$4.38M 0.53%
16,251
-3,174
-16% -$820K
AGIO icon
61
Agios Pharmaceuticals
AGIO
$2.08B
$4.05M 0.49%
+60,000
New +$3.49M
VRTX icon
62
Vertex Pharmaceuticals
VRTX
$123B
$3.73M 0.45%
20,271
-15,946
-44% -$2.95M
EXAS
63
DELISTED
Exact Sciences
EXAS
$3.33M 0.4%
38,400
-95,750
-71% -$8.15M
FSTX
64
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.9M 0.35%
69,164
+6,250
+10% +$263K
KA
65
DELISTED
Kineta, Inc. Common Stock
KA
$2.58M 0.31%
14,645
+3,347
+30% +$1.64M
JNJ icon
66
Johnson & Johnson
JNJ
$640B
$2.49M 0.3%
17,799
– –
URGN icon
67
UroGen Pharma
URGN
$1.97B
$2.4M 0.29%
+65,063
New +$2.73M
MTEM
68
DELISTED
Molecular Templates, Inc.
MTEM
$2.03M 0.24%
23,333
– –
ONC
69
BeOne Medicines Ltd
ONC
$33.9B
$1.44M 0.17%
10,927
-4,000
-27% -$540K
TMO icon
70
Thermo Fisher Scientific
TMO
$214B
$1.25M 0.15%
4,549
– –
HCM icon
71
HUTCHMED
HCM
$1.96B
$967K 0.12%
31,628
– –
ELV icon
72
Elevance Health
ELV
$81.5B
$965K 0.12%
3,361
– –
RDY icon
73
Dr. Reddy's Laboratories
RDY
$9.8B
$798K 0.1%
98,485
+8,000
+9% +$60.8K
BDX icon
74
Becton Dickinson
BDX
$46.4B
$753K 0.09%
3,090
– –
HCA icon
75
HCA Healthcare
HCA
$88.4B
$693K 0.08%
5,316
– –
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Sectoral Asset Management held 117 positions worth $831M, up 13% from $736M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management's Q1 2019 filing shows 13 new, 23 increased, 36 reduced and 11 closed positions. Its largest new stake was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M. The largest sale was Array Biopharma Inc, an estimated $26.1M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q1 2019 buy was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M.
  • Sectoral Asset Management added most to Assembly Biosciences in Q1 2019, an estimated $11.8M increase.
  • Sectoral Asset Management's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $26.1M.
  • Sectoral Asset Management fully exited Immunomedics Inc in Q1 2019, selling an estimated $18.6M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $831M portfolio in Q1 2019.
  • Sectoral Asset Management opened 13 new positions and closed 11 in Q1 2019.
  • Sectoral Asset Management's portfolio value rose 13% quarter-over-quarter to $831M.

Based on Sectoral Asset Management's 13F filing for Q1 2019, filed 14 May 2019.